Clinical trial
Treatment for Hidradenitis Suppurativa
NCT06568224 is registered in ClinicalTrials.gov with The First Affiliated Hospital with Nanjing Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Treatment for Hidradenitis Suppurativa
- Lead sponsor
- The First Affiliated Hospital with Nanjing Medical University
- Phase
- Observational
- Overall status
- Completed
- Start date
- May 1, 2020
- Completion date
- September 1, 2023
- Enrollment
- 27 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.